BiomX Inc. financial data

Symbol
PHGE, PHGE-UN on NYSE, PHGEW on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
708 Quince Orchard Rd, Suite 205, Gaithersburg, MD
Fiscal year end
December 31
Former names
Chardan Healthcare Acquisition Corp. (to 10/23/2019)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 298 % -23.6%
Return On Equity -361 % -182%
Return On Assets -50.4 % +10.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 179M shares +289%
Common Stock, Shares, Outstanding 69.8M shares +51.8%
Entity Public Float 16.5M USD -11%
Common Stock, Value, Issued 5K USD +66.7%
Weighted Average Number of Shares Outstanding, Basic 69.8M shares +35.4%
Weighted Average Number of Shares Outstanding, Diluted 108M shares +109%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 19.3M USD +27.8%
General and Administrative Expense 10.3M USD +20.5%
Operating Income (Loss) -29.6M USD -21.3%
Nonoperating Income (Expense) 329K USD +1.23%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -26.2M USD -3.38%
Income Tax Expense (Benefit) 19K USD -68.9%
Net Income (Loss) Attributable to Parent -26.3M USD -3.2%
Earnings Per Share, Basic 0.46 USD/shares -38.7%
Earnings Per Share, Diluted 0.54 USD/shares -28%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 31.6M USD +6.4%
Cash, Cash Equivalents, and Short-term Investments 38.7M USD -18.1%
Other Assets, Current 2.37M USD -6.37%
Assets, Current 35.1M USD +5.7%
Property, Plant and Equipment, Net 6.95M USD +58.3%
Operating Lease, Right-of-Use Asset 10.4M USD +184%
Intangible Assets, Net (Excluding Goodwill) 382K USD -79.9%
Goodwill 15.8M USD
Other Assets, Noncurrent 378K USD
Assets 68.6M USD +66.3%
Accounts Payable, Current 1.36M USD -2.58%
Contract with Customer, Liability, Current 1.98M USD
Liabilities, Current 7.31M USD -37.4%
Contract with Customer, Liability, Noncurrent 1.98M USD 0%
Operating Lease, Liability, Noncurrent 8.85M USD +161%
Other Liabilities, Noncurrent 153K USD -19.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -143M USD -22.7%
Retained Earnings (Accumulated Deficit) -176M USD -17.6%
Stockholders' Equity Attributable to Parent 27.4M USD +72.9%
Liabilities and Equity 68.6M USD +66.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.4M USD -125%
Net Cash Provided by (Used in) Financing Activities 39M USD +3612%
Net Cash Provided by (Used in) Investing Activities 663K USD -66.7%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 69.8M shares +51.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.01M USD +88.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 32.7M USD +6.69%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.42M USD +187%
Deferred Tax Assets, Valuation Allowance 32.1M USD +15.5%
Deferred Tax Assets, Gross 33.1M USD +14.6%
Operating Lease, Liability 3.91M USD -12.9%
Depreciation 632K USD +13.9%
Payments to Acquire Property, Plant, and Equipment 10K USD -50%
Lessee, Operating Lease, Liability, to be Paid 4.76M USD
Operating Lease, Liability, Current 1.05M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 688K USD -2.96%
Lessee, Operating Lease, Liability, to be Paid, Year One 688K USD -2.96%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 853K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 688K USD -2.96%
Deferred Tax Assets, Operating Loss Carryforwards 29M USD +18.5%
Preferred Stock, Shares Issued 257K shares
Preferred Stock, Shares Authorized 1M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 688K USD -2.96%
Operating Lease, Payments 134K USD
Additional Paid in Capital 171M USD +3.26%
Preferred Stock, Shares Outstanding 257K shares
Amortization of Intangible Assets 1.52M USD 0%
Share-based Payment Arrangement, Expense 77K USD -71.6%
Interest Expense 2.69M USD +23.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%